Hengrui Zhu

Hengrui Zhu

Wistar Institute - Philadelphia / United States
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 4629728
-
person_outline Hengrui Zhu's MOST POPULAR ARTICLES
1-) BET bromodomain inhibition promotes anti-tumor immunity by suppressing PD-L1 expressionH Zhu, F Bengsch, N Svoronos, MR Rutkowski, BG Bitler, MJ Allegrezza, ...Cell reports 16 (11), 2829-2837, 20162872016
2-) BET bromodomain inhibition synergizes with PARP inhibitor in epithelial ovarian cancerS Karakashev, H Zhu, Y Yokoyama, B Zhao, N Fatkhutdinov, ...Cell reports 21 (12), 3398-3405, 20171322017
3-) SATB1 expression governs epigenetic repression of PD-1 in tumor-reactive T cellsTL Stephen, KK Payne, RA Chaurio, MJ Allegrezza, H Zhu, J Perez-Sanz, ...Immunity 46 (1), 51-64, 2017
4-) N6-Methylation of Adenosine of FZD10 mRNA Contributes to PARP Inhibitor ResistanceT Fukumoto, H Zhu, T Nacarelli, S Karakashev, N Fatkhutdinov, S Wu, ...Cancer research 79 (11), 2812-2820, 2019
5-) BET inhibitors suppress ALDH activity by targeting ALDH1A1 super-enhancer in ovarian cancerY Yokoyama, H Zhu, JH Lee, AV Kossenkov, SY Wu, JM Wickramasinghe, ...Cancer research 76 (21), 6320-6330, 2016